141 related articles for article (PubMed ID: 37947846)
21. Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.
Rodrigues G; Bauman G; Venkatesan V; Ahmad B; Lock M; Sexton T; D'Souza D; Stitt L; Eid S
Can J Urol; 2011 Aug; 18(4):5802-10. PubMed ID: 21854712
[TBL] [Abstract][Full Text] [Related]
22. Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.
Guedea F; Ferrer M; Pera J; Aguiló F; Boladeras A; Suárez JF; Cunillera O; Ferrer F; Pardo Y; Martínez E; Ventura M
Clin Transl Oncol; 2009 Jul; 11(7):470-8. PubMed ID: 19574206
[TBL] [Abstract][Full Text] [Related]
23. Cultural adaptation and validation of the Chinese version of the expanded prostate cancer index composite.
Lee TK; Poon DMC; Ng ACF; Ho T; Singh-Carlson S; Joffres M; Oshan G; Kohli J; Kwan W
Asia Pac J Clin Oncol; 2018 Mar; 14 Suppl 1():10-15. PubMed ID: 29508938
[TBL] [Abstract][Full Text] [Related]
24. External validation of predictive models of sexual, urinary, bowel and hormonal function after surgery in prostate cancer subjects.
Borg MA; O'Callaghan ME; Moretti KL; Vincent AD
BMC Urol; 2024 Jan; 24(1):2. PubMed ID: 38166977
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of the korean version of expanded prostate cancer index composite: questionnaire assessing health-related quality of life after prostate cancer treatment.
Chung KJ; Kim JJ; Lim SH; Kim TH; Han DH; Lee SW
Korean J Urol; 2010 Sep; 51(9):601-12. PubMed ID: 20856644
[TBL] [Abstract][Full Text] [Related]
26. Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy.
Wagner AA; Cheng PJ; Carneiro A; Dovirak O; Khosla A; Taylor KN; Crociani CM; McAnally KC; Percy A; Dewey LE; Sanda MG; Chang P
J Urol; 2017 Jan; 197(1):109-114. PubMed ID: 27475967
[TBL] [Abstract][Full Text] [Related]
27. Health related quality of life in Japanese men with localized prostate cancer treated with current multiple modalities assessed by a newly developed Japanese version of the Expanded Prostate Cancer Index Composite.
Kakehi Y; Takegami M; Suzukamo Y; Namiki S; Arai Y; Kamoto T; Ogawa O; Fukuhara S
J Urol; 2007 May; 177(5):1856-61. PubMed ID: 17437836
[TBL] [Abstract][Full Text] [Related]
28. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
[TBL] [Abstract][Full Text] [Related]
29. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
30. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.
Vertosick EA; Vickers AJ; Cowan JE; Broering JM; Carroll PR; Cooperberg MR
J Urol; 2017 Sep; 198(3):671-677. PubMed ID: 28342935
[TBL] [Abstract][Full Text] [Related]
31. Patient-reported outcomes after surgery or radiotherapy for localised prostate cancer: a retrospective study.
Ng CF; Kong KY; Li CY; Li JKT; Li NY; Ng BPK; Leung SCH; Hong CYL; Yee CH; Teoh JYC
Hong Kong Med J; 2020 Apr; 26(2):95-101. PubMed ID: 32245911
[TBL] [Abstract][Full Text] [Related]
32. Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.
Laviana AA; Zhao Z; Huang LC; Koyama T; Conwill R; Hoffman K; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
Eur Urol; 2020 Aug; 78(2):248-255. PubMed ID: 32098731
[TBL] [Abstract][Full Text] [Related]
33. Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice.
Chipman JJ; Sanda MG; Dunn RL; Wei JT; Litwin MS; Crociani CM; Regan MM; Chang P;
J Urol; 2014 Mar; 191(3):638-45. PubMed ID: 24076307
[TBL] [Abstract][Full Text] [Related]
34. Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer.
Bulamu NB; Mpundu-Kaambwa C; O'Callaghan M; Kaambwa B
BMC Cancer; 2023 Apr; 23(1):297. PubMed ID: 37005587
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of expanded prostate cancer index composite (EPIC) quality of life after surgery or radiation treatment.
Lee TK; Breau RH; Mallick R; Eapen L
Can J Urol; 2015 Feb; 22(1):7599-606. PubMed ID: 25694006
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study.
Sureda A; Fumadó L; Ferrer M; Garín O; Bonet X; Castells M; Mir MC; Abascal JM; Vigués F; Cecchini L; Suárez JF
Health Qual Life Outcomes; 2019 Jan; 17(1):11. PubMed ID: 30642340
[TBL] [Abstract][Full Text] [Related]
37. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
Hedgepeth RC; Labo J; Zhang L; Wood DP
J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
[TBL] [Abstract][Full Text] [Related]
38. Prospective longitudinal outcomes of quality of life after laparoscopic radical prostatectomy compared with retropubic radical prostatectomy.
Hashine K; Kakuda T; Iuchi S; Hosokawa T; Ninomiya I
Health Qual Life Outcomes; 2018 Jan; 16(1):7. PubMed ID: 29304808
[TBL] [Abstract][Full Text] [Related]
39. Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry.
Garin O; Kowalski C; Zamora V; Roth R; Ferrer M; Breidenbach C; Pont A; Belin TR; Elashoff D; Wilhalme H; Nguyen AV; Kwan L; Pearman EK; Bolagani A; Sampurno F; Papa N; Moore C; Millar J; Connor SE; Villanti P; Litwin MS;
BMC Urol; 2023 Nov; 23(1):178. PubMed ID: 37919726
[TBL] [Abstract][Full Text] [Related]
40. Stratification of postprostatectomy urinary function using expanded prostate cancer index composite.
Ellison JS; He C; Wood DP
Urology; 2013 Jan; 81(1):56-60. PubMed ID: 23122544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
